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Although cancer is a multifaceted disease, all cancer types share identical molecular and cellular mechanisms. These mechanisms
involve a collection of alterations critical to the normal physiological functioning of cells, such as alterations of growth factor signalling
pathways, angiogenesis, cell adhesion signals, DNA replication and apoptotic cell death. Many genes involved in the processes
enumerated above are functionally inactive in tumour cells, designating them as putative ‘tumour suppressor genes’. Back in the early
1990s, Vogelstein and colleagues suggested that a gene called DCC (for Deleted in Colorectal Cancer) could be a tumour suppressor
gene because it was found to be deleted in more than 70% of colorectal cancers, as well as in many other cancers. During the last 15
years, controversial data have failed to firmly establish whether DCC is indeed a tumour suppressor gene. However, the recent
observations that DCC triggers cell death and is a receptor for netrin-1, a molecule recently implicated in colorectal tumorigenesis,
have prompted a renewal of interest in the role of DCC in tumorigenesis and suggest that the netrin-1/receptor pairs act as novel
negative regulators of tumour development.
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While the classic view of receptor function is mono-sided, that is, a
receptor is inactive until bound and activated by its ligand, during
the last decade it has been suggested that some receptors may
display two sides, a ` la ‘Jeckyll and Hyde’: in the presence of ligand,
these receptors transmit positive signals of differentiation,
proliferation or migration, whereas in the absence of ligand, they
turn into deadly weapons driving cells to commit suicide. Such a
feature should lead cells expressing such receptors to become
dependent on the presence of their ligand for survival.
A growing number of so-called dependence receptors are being
identified: the low-affinity neurotrophin receptor P75
ntr (Rabiza-
deh et al, 1993), the androgen receptor AR (Ellerby et al, 1999), the
DCC (for Deleted in Colorectal Cancer) receptors (Mehlen et al,
1998), RET (REarranged during Transfection) (Bordeaux et al,
2000), UNC5H (Llambi et al, 2001), Patched (Thibert et al, 2003),
neogenin (Matsunaga et al, 2004) and integrins such as avb3 and
a5b1 (Stupack et al, 2001). Interestingly, whereas these receptors
are known to be involved in the development of the nervous
system when bound by their ligand, they each have the ability to
trigger apoptosis in the absence of ligand. We propose to focus on
the role of some of the receptors most extensively studied so far:
the dependence receptors for netrin-1. Netrin-1 is a laminin-
related molecule (Figure 1) initially discovered as a diffusible
molecule produced by a ventral structure in the developing spinal
cord, that is, floor plate, that attracts commissural axons (Serafini
et al, 1994). Netrin-1 is a member of a family of homologous
molecules like netrin-2, netrin-G1, netrin-G2 and netrin-4/b-
netrin. Although next to nothing is known about these molecules,
netrin-1 has been extensively described, particularly by Tessier-
Lavigne and collaborators. As such, netrin-1 was shown to act as a
chemoattractive or chemorepulsive cue for many migrating axons
and neurons. This effect is believed to pass through two main
families of type 1 transmembrane receptors: DCC and its
homologue neogenin and the UNC5H – UNC5 homologue –
receptors (UNC5H1, UNC5H2, UNC5H3, UNC5H4) (Figure 1).
Because netrin-1 and its receptors have already been reviewed for
their role in neuronal guidance (Tessier-Lavigne and Goodman,
1996; Mehlen and Mazelin, 2003; Mehlen and Fearon, 2004), we will
mainly describe here the implications of netrin-1, DCC and
UNC5H in apoptosis and consider the consequences on tumour
escape mechanisms.
ROLE OF DCC AND UNC5H AS DEPENDENCE
RECEPTORS
The role of DCC and UNC5H as receptors for netrin-1, a molecule
involved in axon guidance and neuron migration, suggested that
signal transduction occurred only in the presence of the ligand
netrin-1. Yet, we and others have shown that both DCC and
UNC5H are much more complex. Indeed, we have suggested these
molecules to act as dependence receptors, which are also active in
the absence of their ligand. Various cell transfection or viral
infection experiments have demonstrated that UNC5H or DCC,
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whereas the presence of netrin-1 is sufficient for blocking this
proapoptotic activity (Mehlen et al, 1998; Forcet et al, 2001; Llambi
et al, 2001; Liu et al, 2002; Tanikawa et al, 2003; Thiebault et al,
2003; Williams et al, 2003).
Little is known about the exact mechanism underlying the
proapoptotic activity of DCC and UNC5H. However, both seem to
be cleaved by major proteases of the apoptotic pathway, caspases.
Caspases are cysteine proteases that cleave intracellular proteins
on the carboxyl side of an aspartate residue. Caspases involved in
apoptosis can be split into two groups: initiator caspases (e.g.,
caspase-8 and -9) and effector caspases (e.g., caspase-3, -6 and -7).
Initiator caspases are activated by a death receptor pathway
(caspase-8) or a mitochondrial pathway (caspase-9). Their
activation initiates a proteolytic cascade that results in activation
of the effector caspases, thus rapidly triggering the execution of
apoptosis and ultimately leading to cell death.
The cleavage sites of UNC5H and DCC receptors are recognised
in vitro by caspase-3 (at position 412 for UNC5H and 1290 for
DCC; see Figure 1), which does not necessarily imply that caspase-
3 is responsible for the cleavage of these receptors in vivo (Mehlen
et al, 1998; Llambi et al, 2001). Mutations of the cleavage site
prevent the proapoptotic activity of these receptors, suggesting
that cleavage is a prerequisite for cell death induction by releasing/
exposing a proapoptotic domain named addiction dependence
domain (ADD) lying in the intracellular domain of DCC or
UNC5H.
In UNC5H, the ADD domain is thought to be located
downstream of the caspase cleavage site and to encompass a
death domain very similar to that of proteins like Fas and TNFR
receptors, which are generally considered to mediate apoptotic
signalling (Llambi et al, 2001). How the death domain of UNC5H
induces apoptosis is yet unknown, even though it is probable that
other death domain-containing proteins are required. Along this
line, we recently demonstrated that UNC5H2 interacts with a death
domain-containing serine/threonine kinase protein named death-
associated protein kinase (DAPK) and that DAPK is required for
UNC5H2-induced cell death (Llambi et al, 2005). Besides the death
domain described above, UNC5H receptors harbour another
domain, also involved in cell death, ZU-5. This domain is
homologous to Zona Occludens-1, an intercellular junction protein
involved in signalling. Recently, NRAGE, a protein of the MAGE
(melanoma antigen) family known to be a regulator of apoptosis,
has been identified as a specific binding partner of UNC5H1. The
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Figure 1 Structure of netrin-1 and netrin-1 dependence receptors. DCC is a type I transmembrane protein with an extracellular domain composed of
four immunoglobulin domains, six fibronectin type III domains, a single transmembrane spanning region and a cytoplasmic domain including ADD. The four
UNC5H receptors all have two immunoglobulin domains and two thrombospondin domains in the extracellular region and a ZU-5 domain (a domain of
homology found in Zona Occludens-1 and UNC-5 protein). Their ligand, netrin-1, is a laminin-related secreted protein with V and VI domains (three
epidermal growth factor domains) related to laminin and a positively charged carboxy (C)-terminal domain.
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apoptotic pathway by promoting the degradation of the survival
protein XIAP (X-linked inhibitor of apoptosis), or by activating the
c-Jun N-terminal kinase (JNK) pathway (Williams et al, 2003).
In DCC, the ADD is located upstream of the caspase cleavage site
and is probably exposed through conformational changes after the
caspase-dependent release of the C-terminal domain (Mehlen et al,
1998). The DCC ADD domain has been shown to interact with
caspase-9 in the absence of netrin-1 (Mehlen et al, 1998; Forcet
et al, 2001). As evidenced in vitro so far (Mehlen et al, 1998), this
interaction is hypothesised to activate effector/downstream
caspases, thus forming an amplification loop leading to more
DCC cleavage and apoptotic cell death. Alternatively, other
proteins may also interact with the ADD of DCC, as recently
shown by Chen and colleagues. Indeed, DIP13 (DCC-interacting
protein-13) has been shown to interact with DCC ADD and to
mediate DCC-induced cell death (Liu et al, 2002).
Results obtained in vivo in netrin-1 knockout mice have
confirmed that cells expressing DCC and UNC5H are dependent
on netrin-1 for survival. In the absence of netrin-1, brainstem cells,
especially those expressing DCC and/or UNC5H genes, undergo
massive apoptosis (Llambi et al, 2001). Along the same line, while
looking for a role of UNC5H in axon guidance in Xenopus, Tessier-
Lavigne and co-workers (Hong et al, 1999) used a UNC5H mutant
deleted of its death domain because expression of the wild-type
receptor induced cell death.
The physiological relevance of the ‘negative’ face of these
receptors in the absence of netrin-1 can be dual. Indeed, while DCC
and UNC5H have been shown to impact positively on axon
guidance by acting as receptors for netrin-1, a negative control by
these receptors, that is cell death, can also occur. In this respect,
the dynamic regulation of axons during CNS development may be
a result of a combination of two opposite (negative and positive)
control mechanisms. The negative effect would be a ‘surveillance’
mechanism capable of eliminating cells that are beyond the ligand
source. In CNS cells, the growth and orientation of neurons would
follow receptor-mediated chemoattraction/repulsion pathways
(depending on the receptor expressed at the cell surface) in
response to the source of netrin-1. This response is dependent on
the capacity of receptors to bind netrin-1. When neurons migrate
away from the netrin-1 source, receptors that have become
‘unoccupied’ may induce cell death, thus preventing cells to
migrate to ‘unwanted’ sites.
The second possible role in vivo is to regulate cellular lifespan,
as recently proposed in intestinal villi. Indeed, the expression
profiles of netrin-1 and DCC in the normal intestine and colon
might suggest that cell survival regulation is dependent on the
DCC/netrin-1 pair. In these tissues, the production of netrin-1 is
restricted to the base of the intestinal crypt, whereas DCC is
distributed throughout the villi (Hsu et al, 2001; Mazelin et al,
2004). This goes well with the classic view of highly proliferative
cells in the base of the intestinal crypt that differentiate while
moving to the distal part of the villi/crypt and that eventually
detach and die or die and detach (Figure 2A). In this view,
proliferating crypt cells that express DCC in a netrin-1-rich
environment would be protected from cell death, whereas
epithelial cells that have stopped proliferating to differentiate
and move towards the villus tip would progressively be placed into
a netrin-1-deprived environment, leading to apoptotic cell death
(Figure 2A). In this respect, we have shown that overexpressing
netrin-1 throughout the intestinal epithelium contributes to
reducing apoptosis by approximately 50% (Mazelin et al, 2004).
One may speculate that the apparent proximal-to-distal netrin-1
gradient may function as a regulatory system that limits the
lifespan of cells that undergo (i) multiple proliferative steps within
the crypt and (ii) repeated mechanical and chemical insults
originating from the intestinal lumen, two conditions that may
increase the risk of cell damage and resultant aberrant behaviour.
Consequently, induction of cell death due to the absence of
superficial netrin-1 expression, together with the mechanical
detachment of cells in the lumen, may represent key factors for
limiting the initiation of malignant transformation.
ROLE OF DEPENDENCE RECEPTORS UNC5H AND
DCC IN COLORECTAL TUMORIGENESIS
Due to the dependence mechanism described above, DCC and
UNC5H could potentially be involved in tumour suppression. The
receptor/netrin-1 pairs may indeed limit tumour development by
inducing apoptosis of cells that have acquired transforming
capacities. Any tumour cell submitted to an inadequate/abnormal
environment (highly proliferative cells in an environment with
limited and constant netrin-1 concentration, migration to other
tissues because of metastatic propensities) would display unbound
dependence receptors, thus triggering the proapoptotic activity of
DCC and/or UNC5H, which would ultimately lead to cell death and
subsequent tumour regression. In cancer, deletion of genes coding
for DCC and UNC5H would induce loss of the proapoptotic signal,
thus providing a selective advantage for tumour escape.
Along this line, in the early 1990s, the DCC gene was proposed
as a putative tumour suppressor gene. Data supporting this
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Figure 2 (A) View of normal intestinal villi. Cells are produced in the
intestinal crypts at the base of the villi. As they differentiate, they migrate to
the surface of the epithelium (intestinal lumen) where they are eventually
eliminated. Netrin-1 is preferentially expressed at the base of intestinal
crypts, whereas its receptor DCC is evenly distributed throughout the villi.
Netrin-1 binding to DCC in crypt cells contributes to cell survival. On the
contrary, the absence of netrin-1 at the villus surface induces apoptotic cell
death. (B) View of intestinal villi overexpressing netrin-1. The even
distribution of netrin-1 on the villus surface prevents apoptotic cell death,
thus promoting tumour growth.
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chromosome 18q, was deleted in over 70% of colorectal cancers
and a number of other tumours (Fearon et al, 1990; Cho et al,
1994). Interestingly, in most reports, allelic losses of 18q are
infrequent in early-stage tumours (e.g., small adenomas), but are
common in primary colorectal carcinomas and nearly 100% of
hepatic metastases arising from colorectal primaries, implying that
chromosome 18q loss of heterozygosity (LOH) may contribute
more to progression rather than initiation of colorectal cancer. In
more than 90% of primary colorectal cancers with LOH of
chromosome 18q, DCC is included in the region of allelic loss
(Fearon et al, 1990; Thiagalingam et al, 1996). Most studies have
linked chromosome 18q LOH in colorectal cancers to a reduction
in DCC expression both at the RNA level (Thiagalingam et al, 1996)
and at the protein level (Goi et al, 1998). Loss of heterozygosity of
chromosome 18q and/or decreased DCC expression have also been
seen in various other cancers, including gastric, prostate,
endometrial, ovarian, oesophageal, breast, testicular, glial, neuro-
blastoma and haematologic malignancies (see for review Mehlen
and Fearon, 2004).
Chromosome 18q LOH has been associated with poor prognosis
in colorectal cancer patients lacking lymph nodes or distant
metastases at the time of surgery (so-called stage II), as well as in
patients who have lymph nodes but no distant metastases at the
time of surgery (stage III) (Jen et al, 1994; Ogunbiyi et al, 1998). In
other studies, chromosome 18q LOH has also been associated with
decreased responsiveness to 5-fluorouracil-based adjuvant che-
motherapy regimens in stage III colorectal cancer patients
(Watanabe et al, 2001; Barratt et al, 2002). Loss of DCC expression
was often associated with poor prognosis and increased risk of
metastasis (Shibata et al, 1996; Saito et al, 1999). The data
indicating that 18q allelic loss and decreased DCC expression are
associated with poor prognosis and possibly decreased response to
adjuvant chemotherapy in colorectal cancer patients are interest-
ing and of potential clinical significance. Nevertheless, the findings
do little to establish whether DCC loss/inactivation is a critical
factor in tumorigenesis or merely an epiphenomenon. Some
evidence that DCC inactivation may in fact be associated with
tumorigenic growth properties in colon and other cancers has been
obtained. For example, introduction of an intact copy of
chromosome 18 into a colorectal cancer cell line lacking
endogenous DCC expression yielded detectable levels of DCC
transcripts and resulted in suppression of growth in soft agar and
tumorigenicity in nude mice (Tanaka et al, 1991). Also, ectopic
expression of DCC in a tumorigenic keratinocyte cell line lacking
endogenous DCC expression was shown to suppress tumorigenic
growth of the cells in nude mice (Klingelhutz et al, 1993).
Interestingly, in this study, it was observed that tumorigenic
reversion was associated with loss of DCC expression and loss or
rearrangement of the transfected DCC expression vector (Klingel-
hutz et al, 1993). Several more recent studies also indicate that
restoration of DCC expression can suppress tumorigenic growth
properties in vitro or in nude mice (Velcich et al, 1999; Kato et al,
2000). More recently, an interesting study suggested that the DCC/
netrin-1 pair is important in endometrial carcinogenesis because
(i) DCC is lost in nearly all the endometrial cancer cell lines tested
and (ii) re-expression of DCC in these cell lines drives apoptosis, a
phenomenon blocked by the presence of netrin-1 (Kato et al,
2004). However, beside these numerous arguments towards a role
of DCC as a tumour suppressor gene, various concerns, such as the
rarity of point mutations identified in DCC coding sequences, the
absence of DCC germline mutations involved in a heritable cancer
predisposition or the lack of a tumour predisposition phenotype in
mice heterozygous for Dcc inactivating mutations, together with
the presence of other known and candidate tumour suppressor
genes on chromosome 18q have raised questions about the role of
DCC. However, as discussed in detail in another review (see
Mehlen and Fearon, 2004), none of these concerns appears
sufficient to discard the hypothesis that DCC acts as a tumour
suppressor gene.
Similarly, it has been observed that the expression of UNC5H is
strongly reduced in more than 90% of colorectal cancers, as well as
in many other tumours. In colorectal cancers, this reduction has
been mostly associated with UNC5H1 and UNC5H3 (Thiebault
et al, 2003). In this case, allelic losses have been observed, but it is
tempting to attribute the loss of UNC5H expression to epigenetic
mechanisms such as promoter methylation (Thiebault et al, 2003).
Moreover, UNC5H2 has been shown to be a direct transcriptional
target of the p53 tumour suppressor gene whose proapoptotic
activity is known to be dependent on the p53-dependent
expression of UNC5H2 and can be antagonised by the presence
of netrin-1 (Tanikawa et al, 2003). Moreover, several in vitro
experiments have shown that DCC and UNC5H compromise the
hallmark features of cell transformation: anchorage-independent
growth and ability to invade through a Matrigel matrix (Thiebault
et al, 2003; Mehlen and Fearon, 2004).
To evaluate the role of DCC and UNC5H receptors in
tumorigenesis and to avoid the usual bias of using inactivating
strategies (knockout) in which both the positive (netrin-1-
dependent signals) and the negative (apoptosis in the absence of
netrin-1) pathways are inactivated, we have developed an
alternative method. We have forced mice to overexpress netrin-1
in the intestinal epithelium, a model that has enabled us to prevent
receptor-induced cell death (Figure 2B). Indeed, it has been
reported that the targeted overexpression of netrin-1 throughout
the digestive tract can produce approximately 50% cell death
inhibition in the intestinal epithelium (Mazelin et al, 2004). This
inhibition of cell death, in agreement with the model proposed for
cell lifespan regulated by netrin-1 control of DCC-induced cell
death, is associated with the formation of numerous focal
hyperplasias (compared to control mice) and of adenomas
(Mazelin et al, 2004). Thus, inhibition of cell death by netrin-1 is
associated with an increased initiation of colorectal tumorigenesis.
Because DCC loss in humans is very often considered as a late
event, netrin-1-overexpressing mice are backcrossed in a mouse
model in which colorectal tumorigenesis is initiated by a mutation
in adenomatous polyposis coli (APC) (Fodde et al, 1994).
Interestingly, while APC mutated mice develop low-grade adeno-
mas, the development of tumours in the APC/netrin-1 mice was
pushed towards high-grade adenoma and adenocarcinoma (Ma-
zelin et al, 2004). The above results demonstrate that blocking cell
death induced by netrin-1 overexpression is associated with both
an initiation and a progression of colorectal tumorigenesis
(Mazelin et al, 2004), thus confirming that dependence receptors
expressed in the digestive tract play a role in tumorigenesis.
Several key issues remain to be answered. First, which is the
receptor involved? Indeed, whether it is DCC or UNC5H1-3
remains to be shown. Interestingly, UNC5H and DCC proteins
display a distinct localisation inside the intestinal villi: UNC5H2
and DCC appear to be present along the whole intestinal villi, while
UNC5H3 is present only within the crypt (Mazelin et al, 2004).
Together with the fact that overexpression of netrin-1 in the mouse
model described above shows two ‘time window’ effects – one
during early phase of tumorigenesis, as illustrated by the
adenomas and focal hyperplasias observed in these mice, and
one late effect with the formation of adenoma-carcinomas in the
APC/netrin-1 mice – this would point to regulatory functions of
these dependence receptors at different times of colorectal
tumorigenesis. A second question is related to netrin-1 expression
in human colorectal tumours, as it would be expected that a similar
selective advantage for a tumour is either to lose receptor
expression (as it occurs for DCC and/or UNC5H) or to gain
netrin-1 expression. A preliminary set of data has shown that
overexpression of netrin-1 is only rarely associated with human
colorectal cancer –7% of the tested tumours (Mazelin et al, 2004) –
therefore suggesting that gain of netrin-1 or loss of the receptor
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have to analyse whether this effect is restricted to colorectal
cancers or if it is general to cancer development.
More work has to be performed to prove that the effect seen in
netrin-1-overexpressing mice is indeed due to the inhibition of
DCC- or UNC5H-induced cell death by netrin-1 and not to the
fact that netrin-1 overexpression leads to overstimulation of
alternative receptors, such as integrins or A2b, nor to the fact that
netrin-1 has a positive effect on tumour development due to
chemoattrative/chemorepulsive activities. Indeed, it was recently
suggested that UNC5H2 plays a role in embryonic angiogenesis,
even though this probably occurs independently of netrin-1
(Lu et al, 2004). It was also shown that netrin-1 can enhance
angiogenesis in a DCC/UNC5H-independent mechanism (Park
et al, 2004). However, it is fair to say that netrin-1 receptors such
as DCC and UNC5H are probably involved in tumour growth
control and can thus be seen as tumour suppressors, even though
their proactivities in low netrin-1 presence largely differ from the
growth inhibitory activity of other known tumour suppressors
such as Rb that constitutively repress cell cycle. DCC and UCN5H
only acquire their suppressive activity when cells grow abnor-
mally and/or migrate to ‘unwanted’ sites where the ligand
concentration is low. This is why we have named these receptors
‘conditional’ tumour suppressors. Whether these conditional
tumour suppressors or their proapoptotic signalling pathways
will turn out to be interesting targets for cancer therapy remains
to be investigated.
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